Publikationen von Yvonne Genzel
Alle Typen
Zeitschriftenartikel (102)
2018
Zeitschriftenartikel
36 (22), S. 3124 - 3133 (2018)
High-cell-density cultivations to increase MVA virus production. Vaccine
Zeitschriftenartikel
102 (3), S. 1167 - 1177 (2018)
Cell culture-based production of defective interfering particles for influenza antiviral therapy. Applied Microbiology and Biotechnology 2017
Zeitschriftenartikel
12 (8), e0182553 (2017)
Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems. PLoS One 2016
Zeitschriftenartikel
11 (10), S. 1332 - 1342 (2016)
Ezrin and HNRNP expression correlate with increased virus release rate and early onset of virus-induced apoptosis of MDCK suspension cells. Biotechnology Journal
Zeitschriftenartikel
113 (1), S. 150 - 162 (2016)
Increased titer and reduced lactate accumulation in recombinant retrovirus production through the down-regulation of HIF1 and PDK. Biotechnology and Bioengineering
Zeitschriftenartikel
100 (5), S. 2121 - 2132 (2016)
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. Applied Microbiology and Biotechnology 2015
Zeitschriftenartikel
99 (17), S. 7059 - 7068 (2015)
Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells. Applied Microbiology and Biotechnology
Zeitschriftenartikel
14 (9), S. 1181 - 1191 (2015)
Bioreactor concepts for cell culture-based viral vaccine production. Expert Review of Vaccines
Zeitschriftenartikel
10 (5), S. 728 - 740 (2015)
Designing cell lines for viral vaccine production: Where do we stand? Biotechnology Journal
Zeitschriftenartikel
33 (35), S. 4269 - 4280 (2015)
Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension. Vaccine 2014
Zeitschriftenartikel
32 (24), S. 2770 - 2781 (2014)
High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine
Zeitschriftenartikel
14, S. 72 (2014)
The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis. BMC Biotechnology
Zeitschriftenartikel
178, S. 43 - 53 (2014)
The influence of cell growth and enzyme activity changes on intracellular metabolite dynamics in AGE1.HN.AAT cells. Journal of Biotechnology
Zeitschriftenartikel
98 (1), S. 385 - 397 (2014)
Changes in intracellular metabolite pools during growth of adherent MDCK cells in two different media. Applied Microbiology and Biotechnology
Zeitschriftenartikel
32 (8), S. 1003 - 1011 (2014)
Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine 2013
Zeitschriftenartikel
8 (9), S. e72288 (2013)
Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles. PLoS One
Zeitschriftenartikel
97 (1), S. 111 - 122 (2013)
CAP, a new human suspension cell line for influenza virus production. Applied Microbiology and Biotechnology
Zeitschriftenartikel
47 (1), S. 12 - 22 (2013)
Herstellung moderner Grippeimpfstoffe: Zellkultur statt Hühnerei. Chemie in unserer Zeit
Zeitschriftenartikel
110 (10), S. 2633 - 2642 (2013)
Evaluating differences of metabolic performances: Statistical methods and their application to animal cell cultivations. Biotechnology and Bioengineering
Zeitschriftenartikel
1 (1), S. 100 - 121 (2013)
Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara. Microorganisms